These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 39063228)

  • 1. [Effect of drugs on regulatory enzymes in metabolic pathways].
    Gumińska M
    Folia Med Cracov; 1980; 22(3-4):241-61. PubMed ID: 7026383
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of Cell-Permeable Allosteric Inhibitors of Liver Pyruvate Kinase: Design and Synthesis of Sulfone-Based Urolithins.
    Iqbal S; Islam MZ; Ashraf S; Kim W; Al-Sharabi AA; Ozcan M; Hanashalshahaby E; Zhang C; Uhlén M; Boren J; Turkez H; Mardinoglu A
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfone-based human liver pyruvate kinase inhibitors - Design, synthesis and in vitro bioactivity.
    Matić J; Akladios F; Battisti UM; Håversen L; Nain-Perez A; Füchtbauer AF; Kim W; Monjas L; Rivero AR; Borén J; Mardinoglu A; Uhlen M; Grøtli M
    Eur J Med Chem; 2024 Apr; 269():116306. PubMed ID: 38471358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel JNK inhibitors targeting liver pyruvate kinase for the treatment of non-alcoholic fatty liver disease and hepatocellular carcinoma.
    Iqbal S; Sebhaoui J; Ashraf S; Ozcan M; Kim W; Belmen B; Yeşilyurt G; Hanashalshahaby E; Zhang C; Uhlen M; Boren J; Turkez H; Mardinoglu A
    Bioorg Chem; 2024 Jun; 147():107425. PubMed ID: 38714117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enediynyl peptides and iso-coumarinyl methyl sulfones as inhibitors of proprotein convertases PCSK8/SKI-1/S1P and PCSK4/PC4: Design, synthesis and biological evaluations.
    Basak A; Goswami M; Rajkumar A; Mitra T; Majumdar S; O'Reilly P; Bdour HM; Trudeau VL; Basak A
    Bioorg Med Chem Lett; 2015; 25(10):2225-37. PubMed ID: 25881830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine-Derived Phosphoeleganin and Its Semisynthetic Derivative Decrease IL6 Levels and Improve Insulin Signaling in Human Hepatocellular Carcinoma Cells.
    Agognon AL; Casertano M; Vito A; Orso S; Cabaro S; Mormone F; Morelli C; Perruolo G; Formisano P; Menna M; Imperatore C; Oriente F
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an
    Kim W; Li M; Jin H; Yang H; Türkez H; Uhlén M; Zhang C; Mardinoglu A
    iScience; 2023 Oct; 26(10):107727. PubMed ID: 37674987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Novel Urolithin C Derivatives as Non-Competitive Inhibitors of Liver Pyruvate Kinase.
    Battisti UM; Monjas L; Akladios F; Matic J; Andresen E; Nagel CH; Hagkvist M; Håversen L; Kim W; Uhlen M; Borén J; Mardinoğlu A; Grøtli M
    Pharmaceuticals (Basel); 2023 Apr; 16(5):. PubMed ID: 37242451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jmjd4 Facilitates Pkm2 Degradation in Cardiomyocytes and Is Protective Against Dilated Cardiomyopathy.
    Tang Y; Feng M; Su Y; Ma T; Zhang H; Wu H; Wang X; Shi S; Zhang Y; Xu Y; Hu S; Wei K; Xu D
    Circulation; 2023 May; 147(22):1684-1704. PubMed ID: 37066795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase.
    Battisti UM; Gao C; Akladios F; Kim W; Yang H; Bayram C; Bolat I; Kiliclioglu M; Yuksel N; Tozlu OO; Zhang C; Sebhaoui J; Iqbal S; Shoaie S; Hacimuftuoglu A; Yildirim S; Turkez H; Uhlen M; Boren J; Mardinoglu A; Grøtli M
    Nutrients; 2023 Jan; 15(3):. PubMed ID: 36771285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuning liver pyruvate kinase activity up or down with a new class of allosteric modulators.
    Nain-Perez A; Nilsson O; Lulla A; Håversen L; Brear P; Liljenberg S; Hyvönen M; Borén J; Grøtli M
    Eur J Med Chem; 2023 Mar; 250():115177. PubMed ID: 36753880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning.
    Zhang C; Shi M; Kim W; Arif M; Klevstig M; Li X; Yang H; Bayram C; Bolat I; Tozlu ÖÖ; Hacımuftuoglu A; Yıldırım S; Sebhaoui J; Iqbal S; Wei Y; Shi X; Nielsen J; Turkez H; Uhlen M; Boren J; Mardinoglu A
    EBioMedicine; 2022 Sep; 83():104214. PubMed ID: 35988463
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.